Data-driven insights from the CardioMEMS™ HF System are an effective way to fine tune GDMT1-3 for better patient outcomes in both HFrEF and HFpEF patients. The CardioMEMS HF System is clinically proven to deliver:
25% reduced risk of heart failure mortality1,4-5
Reversal in patient symptoms from Class III to Class II2,3
Learn about hemodynamic management with CardioMEMS HF System.
Access comprehensive clinical data, trial outcomes and more educational resources for healthcare professionals working in heart failure
DOWNLOAD THE HIGHLIGHTS: Sign up to get data on remote hemodynamic monitoring of PA pressures in patients with chronic heart failure
Banner 4
Remote Hemodynamic Monitoring: The Totality of Evidence
Listen to a discussion breaking down the totality of clinical data which supports the use of remote hemodynamic monitoring in patients with a heart failure diagnosis.
Givertz MM, Stevenson LW, Costanzo MR, et al; CHAMPION Trial Investigators. Pulmonary artery pressure-guided management of patients with heart failure and reduced ejection fraction. J Am Coll Cardiol. 2017;70(15):1875-1886. doi:10.1016/j.jacc.2017.08.010.
Mehra M, et al; GUIDE-HF Trial Investigators; Primary Results of the Prospective Single Arm Trial of Hemodynamic-Guided Management of Heart Failure (GUIDE-HF). Presented at HFSA Conference; October 2023; Cleveland, OH.
Brugts, J et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. The Lancet. May 20, 2023. https://doi.org/10.1016/S0140-6736(23)00923-6.
Lindenfeld, J, Costanzo, M, Zile, M. et al. Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection Fraction. J Am Coll Cardiol. 2024 Feb, 83 (6) 682–694.
Abraham J, Bharmi R, Jonsson O, et al. Association of ambulatory hemodynamic monitoring of heart failure with clinical outcomes in a concurrent matched cohort analysis [published correction appears in JAMA Cardiol. 2019;4(6):601]. JAMA Cardiol. 2019;4(6):556-563. doi:10.1001/jamacardio.2019.1384